- Home
- BTAI vs ONMD Comparison
BTAI vs ONMD Comparison
Compare BTAI & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- ONMD
- Stock Information
- Founded
- BTAI 2017
- ONMD 2006
- Country
- BTAI United States
- ONMD United States
- Employees
- BTAI N/A
- ONMD N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- BTAI Health Care
- ONMD
- Exchange
- BTAI Nasdaq
- ONMD Nasdaq
- Market Cap
- BTAI 48.3M
- ONMD 43.5M
- IPO Year
- BTAI 2018
- ONMD N/A
- Fundamental
- Price
- BTAI $2.05
- ONMD $2.12
- Analyst Decision
- BTAI Buy
- ONMD
- Analyst Count
- BTAI 5
- ONMD 0
- Target Price
- BTAI $32.80
- ONMD N/A
- AVG Volume (30 Days)
- BTAI 987.3K
- ONMD 17.6M
- Earning Date
- BTAI 11-12-2025
- ONMD 12-16-2025
- Dividend Yield
- BTAI N/A
- ONMD N/A
- EPS Growth
- BTAI N/A
- ONMD N/A
- EPS
- BTAI N/A
- ONMD N/A
- Revenue
- BTAI $868,000.00
- ONMD $459,000.00
- Revenue This Year
- BTAI N/A
- ONMD N/A
- Revenue Next Year
- BTAI $614.78
- ONMD N/A
- P/E Ratio
- BTAI N/A
- ONMD N/A
- Revenue Growth
- BTAI N/A
- ONMD N/A
- 52 Week Low
- BTAI $1.17
- ONMD $0.30
- 52 Week High
- BTAI $12.16
- ONMD $4.22
- Technical
- Relative Strength Index (RSI)
- BTAI 34.65
- ONMD 50.80
- Support Level
- BTAI $2.14
- ONMD $2.10
- Resistance Level
- BTAI $2.46
- ONMD $2.40
- Average True Range (ATR)
- BTAI 0.16
- ONMD 0.29
- MACD
- BTAI -0.00
- ONMD -0.11
- Stochastic Oscillator
- BTAI 9.03
- ONMD 8.47
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its innovative solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. OneMedNet's innovative technology proved the commercial and regulatory viability of imaging Real World Data (as defined below), an emerging market, and provides regulatory-grade image-centric iRWDTM that exactly matches OneMedNet's life science partners' case selection protocols and paves the way for Real World Evidence.